Litigation Details for Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals (Fed. Cir. 2014)
✉ Email this page to a colleague
Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals (Fed. Cir. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-01-29 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | RE38,743 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals (Fed. Cir. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-06-27 | 49 | Oligosaccharide Mapping of Low Molecular RE38,743 E 6/2005 Debrie … TITLE 35—PATENTS PART III—PATENTS AND PROTECTION OF PATENT RIGHTS …circumstances, the patent owner has market power in the relevant market for the patent or patented product on… in a patent or the use of which is claimed in a patent before the expiration of such patent. …Amphastar uses Momenta’s patented methods. Even though Momenta’s patent is fully in force, | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
